GSK ups sales guidance on back of Shingrix strength
GSK’s first quarter following the demerger of its consumer health business sees the company raise its 2022 sales guidance to between 6-8%, up from 5-7% on its previous estimation.
Archives for August 1, 2022
Merck picks up another ADC agreement
With speculation that Merck is lining up a multi-billion dollar acquisition in the ADC space, the company has agreed a second collaboration deal with Sichuan Kelun Pharmaceutical.
Emergex starts up production for universal influenza vaccine
The UK company plans to manufacture sufficient levels of its universal influenza vaccine for use in Phase I human trials.
Pfizer and BioNTech start trial of ‘next-gen’ COVID vaccine
The two companies have begun a Phase II study on an ‘enhanced’ version of their mRNA vaccine against COVID-19.